» Articles » PMID: 28059080

Scaling of Titanium Implants Entrains Inflammation-induced Osteolysis

Overview
Journal Sci Rep
Specialty Science
Date 2017 Jan 7
PMID 28059080
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

With millions of new dental and orthopedic implants inserted annually, periprosthetic osteolysis becomes a major concern. In dentistry, peri-implantitis management includes cleaning using ultrasonic scaling. We examined whether ultrasonic scaling releases titanium particles and induces inflammation and osteolysis. Titanium discs with machined, sandblasted/acid-etched and sandblasted surfaces were subjected to ultrasonic scaling and we physically and chemically characterized the released particles. These particles induced a severe inflammatory response in macrophages and stimulated osteoclastogenesis. The number of released particles and their chemical composition and nanotopography had a significant effect on the inflammatory response. Sandblasted surfaces released the highest number of particles with the greatest nanoroughness properties. Particles from sandblasted/acid-etched discs induced a milder inflammatory response than those from sandblasted discs but a stronger inflammatory response than those from machined discs. Titanium particles were then embedded in fibrin membranes placed on mouse calvariae for 5 weeks. Using micro-CT, we observed that particles from sandblasted discs induced more osteolysis than those from sandblasted/acid-etched discs. In summary, ultrasonic scaling of titanium implants releases particles in a surface type-dependent manner and may aggravate peri-implantitis. Future studies should assess whether surface roughening affects the extent of released wear particles and aseptic loosening of orthopedic implants.

Citing Articles

Impact of Glow-Discharge Nitriding Technology on the Properties of 3D-Printed Grade 2 Titanium Alloy.

Kaminski J, Sitek R, Adamczyk-Cieslak B, Kulikowski K Materials (Basel). 2024; 17(18).

PMID: 39336333 PMC: 11433006. DOI: 10.3390/ma17184592.


Beyond hype: unveiling the Real challenges in clinical translation of 3D printed bone scaffolds and the fresh prospects of bioprinted organoids.

Zhao X, Li N, Zhang Z, Hong J, Zhang X, Hao Y J Nanobiotechnology. 2024; 22(1):500.

PMID: 39169401 PMC: 11337604. DOI: 10.1186/s12951-024-02759-z.


Peri-implantitis induction and resolution around zirconia versus titanium implants.

Esplin K, Tsai Y, Vela K, Diogenes A, Hachem L, Palaiologou A J Periodontol. 2024; 95(12):1180-1189.

PMID: 39003566 PMC: 11708443. DOI: 10.1002/JPER.23-0573.


Assessing the Impact of Various Decontamination Instruments on Titanium and Zirconia Dental Implants: An In Vitro Study.

Vierling L, Liu C, Wiedemeier D, Gubler A, Schmidlin P Dent J (Basel). 2024; 12(5).

PMID: 38786534 PMC: 11119916. DOI: 10.3390/dj12050136.


Quantity and Size of Titanium Particles Released from Different Mechanical Decontamination Procedures on Titanium Discs: An In Vitro Study.

Kao A, Tawse-Smith A, Ma S, Duncan W, Reid M, Atieh M Dent J (Basel). 2024; 12(5).

PMID: 38786521 PMC: 11119952. DOI: 10.3390/dj12050123.


References
1.
Chen W, Li Z, Guo Y, Zhou Y, Zhang Y, Luo G . Wear Particles Impair Antimicrobial Activity Via Suppression of Reactive Oxygen Species Generation and ERK1/2 Phosphorylation in Activated Macrophages. Inflammation. 2015; 38(3):1289-96. DOI: 10.1007/s10753-014-0099-4. View

2.
Kudo O, Fujikawa Y, Itonaga I, Sabokbar A, Torisu T, Athanasou N . Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation. J Pathol. 2002; 198(2):220-7. DOI: 10.1002/path.1190. View

3.
Takeshita S, Kaji K, Kudo A . Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res. 2000; 15(8):1477-88. DOI: 10.1359/jbmr.2000.15.8.1477. View

4.
Schmage P, Thielemann J, Nergiz I, Scorziello T, Pfeiffer P . Effects of 10 cleaning instruments on four different implant surfaces. Int J Oral Maxillofac Implants. 2012; 27(2):308-17. View

5.
Ngoh E, Weisser S, Lo Y, Kozicky L, Jen R, Brugger H . Activity of SHIP, Which Prevents Expression of Interleukin 1β, Is Reduced in Patients With Crohn's Disease. Gastroenterology. 2015; 150(2):465-76. DOI: 10.1053/j.gastro.2015.09.049. View